Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Journal of Applied Physiology (Bethesda, Md. : 1985)|May 1, 1996
Differential effects of salmeterol on lung endothelial and epithelial leakage in sheepB T Peterson, D E Griffith, J C Connelly, et al.
The American Review of Respiratory Disease|June 1, 1989
Alveolar macrophages from patients with asbestos exposure release increased levels of leukotriene B4J G Garcia, D E Griffith, A B Cohen, et al.
The American Review of Respiratory Disease|December 1, 1982
The value of bronchoscopy in establishing the etiology of pneumonia in renal transplant recipientsL L Hedemark, R S Kronenberg, F L Rasp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung diseaseD E Griffith, B A Brown, W M Girard, et al.
The Annals of Thoracic Surgery|September 2, 1998
Results of operation in Mycobacterium avium-intracellulare lung diseaseK G Nelson, D E Griffith, B A Brown, et al.
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine|August 1, 1974
Dual camera studies of pulmonary function with computer processing of dataM K Loken, R A Ponto, R S Kronenberg, et al.
The Journal of Infectious Diseases|March 1, 1995
Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infectionR J Wallace, B A Brown, D E Griffith, et al.
Thrombosis Research|May 1, 1994
Growth factors for human pleural mesothelial cells in soluble products from formed clotsD E Griffith, A R Johnson, A Kumar, et al.
The European Respiratory Journal|December 6, 2000
Modulation by pentobarbital of neutrophil responses to inhaled E. coli endotoxin in sheep: role of lung epitheliumB T Peterson, E J Miller, D E Griffith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
Relationship of adverse events to serum drug levels in patients receiving high-dose azithromycin for mycobacterial lung diseaseB A Brown, D E Griffith, W Girard, et al.
Pageof 8